Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

A new data effort to inform career choices in biomedicine.

Blank R, Daniels RJ, Gilliland G, Gutmann A, Hawgood S, Hrabowski FA, Pollack ME, Price V, Reif LR, Schlissel MS.

Science. 2017 Dec 15;358(6369):1388-1389. doi: 10.1126/science.aar4638. No abstract available.

PMID:
29242335
2.

Innate immunity of surfactant proteins A and D in urinary tract infection with uropathogenic Escherichia coli.

Hu F, Ding G, Zhang Z, Gatto LA, Hawgood S, Poulain FR, Cooney RN, Wang G.

Innate Immun. 2016 Jan;22(1):9-20. doi: 10.1177/1753425915609973. Epub 2015 Oct 28.

3.

Protective Role of Surfactant Protein D in Ocular Staphylococcus aureus Infection.

Zhang Z, Abdel-Razek O, Hawgood S, Wang G.

PLoS One. 2015 Sep 23;10(9):e0138597. doi: 10.1371/journal.pone.0138597. eCollection 2015.

4.

Precision medicine: Beyond the inflection point.

Hawgood S, Hook-Barnard IG, O'Brien TC, Yamamoto KR.

Sci Transl Med. 2015 Aug 12;7(300):300ps17. doi: 10.1126/scitranslmed.aaa9970. Review.

PMID:
26268311
5.

Commentary: Team science.

O'Brien T, Yamamoto K, Hawgood S.

Acad Med. 2013 Feb;88(2):156-7. doi: 10.1097/ACM.0b013e31827c0e34.

PMID:
23361027
6.

Mice deficient in surfactant protein A (SP-A) and SP-D or in TLR2 manifest delayed parturition and decreased expression of inflammatory and contractile genes.

Montalbano AP, Hawgood S, Mendelson CR.

Endocrinology. 2013 Jan;154(1):483-98. doi: 10.1210/en.2012-1797. Epub 2012 Nov 26.

7.

Surfactant protein d deficiency in mice is associated with hyperphagia, altered fat deposition, insulin resistance, and increased basal endotoxemia.

Stidsen JV, Khorooshi R, Rahbek MK, Kirketerp-Møller KL, Hansen PB, Bie P, Kejling K, Mandrup S, Hawgood S, Nielsen O, Nielsen CH, Owens T, Holmskov U, Sørensen GL.

PLoS One. 2012;7(4):e35066. doi: 10.1371/journal.pone.0035066. Epub 2012 Apr 11.

8.

Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity.

Keller RL, Tacy TA, Hendricks-Munoz K, Xu J, Moon-Grady AJ, Neuhaus J, Moore P, Nobuhara KK, Hawgood S, Fineman JR.

Am J Respir Crit Care Med. 2010 Aug 15;182(4):555-61. doi: 10.1164/rccm.200907-1126OC. Epub 2010 Apr 22.

9.

Susceptibility of mice genetically deficient in SP-A or SP-D gene to invasive pulmonary aspergillosis.

Madan T, Reid KB, Clark H, Singh M, Nayak A, Sarma PU, Hawgood S, Kishore U.

Mol Immunol. 2010 Jun;47(10):1923-30. doi: 10.1016/j.molimm.2010.02.027. Epub 2010 Apr 21.

PMID:
20413160
10.

Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model.

Mun JJ, Tam C, Kowbel D, Hawgood S, Barnett MJ, Evans DJ, Fleiszig SM.

Infect Immun. 2009 Jun;77(6):2392-8. doi: 10.1128/IAI.00173-09. Epub 2009 Apr 6.

11.

A recombinant fragment of human surfactant protein D lacking the short collagen-like stalk fails to correct morphological alterations in lungs of SP-D deficient mice.

Knudsen L, Wucherpfennig K, Mackay RM, Townsend P, Mühlfeld C, Richter J, Hawgood S, Reid K, Clark H, Ochs M.

Anat Rec (Hoboken). 2009 Feb;292(2):183-9. doi: 10.1002/ar.20830.

12.

Simultaneous absence of surfactant proteins A and D increases lung inflammation and injury after allogeneic HSCT in mice.

Gram K, Yang S, Steiner M, Somani A, Hawgood S, Blazar BR, Panoskaltsis-Mortari A, Haddad IY.

Am J Physiol Lung Cell Mol Physiol. 2009 Feb;296(2):L167-75. doi: 10.1152/ajplung.90253.2008. Epub 2008 Nov 7.

13.

Expression of surfactant protein D in human corneal epithelial cells is upregulated by Pseudomonas aeruginosa.

Ni M, Tam C, Verma A, Ramphal R, Hawgood S, Evans DJ, Fleiszig SM.

FEMS Immunol Med Microbiol. 2008 Nov;54(2):177-84. doi: 10.1111/j.1574-695X.2008.00461.x. Epub 2008 Jul 22.

14.

Laser microdissection allows detection of abnormal gene expression in cystic adenomatoid malformation of the lung.

Jancelewicz T, Nobuhara K, Hawgood S.

J Pediatr Surg. 2008 Jun;43(6):1044-51. doi: 10.1016/j.jpedsurg.2008.02.027.

PMID:
18558180
15.

Genetic analysis of congenital cystic adenomatoid malformation reveals a novel pulmonary gene: fatty acid binding protein-7 (brain type).

Wagner AJ, Stumbaugh A, Tigue Z, Edmondson J, Paquet AC, Farmer DL, Hawgood S.

Pediatr Res. 2008 Jul;64(1):11-6. doi: 10.1203/PDR.0b013e318174eff8.

PMID:
18391847
16.

Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient mice.

Knudsen L, Ochs M, Mackay R, Townsend P, Deb R, Mühlfeld C, Richter J, Gilbert F, Hawgood S, Reid K, Clark H.

Respir Res. 2007 Oct 3;8:70.

17.

Integrin beta6 mediates phospholipid and collectin homeostasis by activation of latent TGF-beta1.

Koth LL, Alex B, Hawgood S, Nead MA, Sheppard D, Erle DJ, Morris DG.

Am J Respir Cell Mol Biol. 2007 Dec;37(6):651-9. Epub 2007 Jul 19.

18.

N-linked glycosylation attenuates H3N2 influenza viruses.

Vigerust DJ, Ulett KB, Boyd KL, Madsen J, Hawgood S, McCullers JA.

J Virol. 2007 Aug;81(16):8593-600. Epub 2007 Jun 6.

19.

Helicobacter infection in the surfactant protein D-deficient mouse.

Khamri W, Worku ML, Anderson AE, Walker MM, Hawgood S, Reid KB, Clark HW, Thursz MR.

Helicobacter. 2007 Apr;12(2):112-23.

PMID:
17309747
20.

Role of surfactant protein-A (SP-A) in lung injury in response to acute ozone exposure of SP-A deficient mice.

Haque R, Umstead TM, Ponnuru P, Guo X, Hawgood S, Phelps DS, Floros J.

Toxicol Appl Pharmacol. 2007 Apr 1;220(1):72-82. Epub 2006 Dec 23.

21.

Surfactant protein D of the innate immune defence is inversely associated with human obesity and SP-D deficiency infers increased body weight in mice.

Sorensen GL, Hjelmborg JV, Leth-Larsen R, Schmidt V, Fenger M, Poulain F, Hawgood S, Sørensen TI, Kyvik KO, Holmskov U.

Scand J Immunol. 2006 Dec;64(6):633-8.

22.

Abnormal vascular tone in infants and children with lung hypoplasia: Findings from cardiac catheterization and the response to chronic therapy.

Keller RL, Moore P, Teitel D, Hawgood S, McQuitty J, Fineman JR.

Pediatr Crit Care Med. 2006 Nov;7(6):589-94.

PMID:
17006391
23.

Deletion of the transmembrane transporter ABCG1 results in progressive pulmonary lipidosis.

Baldán A, Tarr P, Vales CS, Frank J, Shimotake TK, Hawgood S, Edwards PA.

J Biol Chem. 2006 Sep 29;281(39):29401-10. Epub 2006 Aug 3.

24.

IL-4 and IL-13 form a negative feedback circuit with surfactant protein-D in the allergic airway response.

Haczku A, Cao Y, Vass G, Kierstein S, Nath P, Atochina-Vasserman EN, Scanlon ST, Li L, Griswold DE, Chung KF, Poulain FR, Hawgood S, Beers MF, Crouch EC.

J Immunol. 2006 Mar 15;176(6):3557-65.

25.

Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa.

Giannoni E, Sawa T, Allen L, Wiener-Kronish J, Hawgood S.

Am J Respir Cell Mol Biol. 2006 Jun;34(6):704-10. Epub 2006 Feb 2.

26.

Early variable-flow nasal continuous positive airway pressure in infants < or =1000 grams at birth.

Jegatheesan P, Keller RL, Hawgood S.

J Perinatol. 2006 Mar;26(3):189-96.

PMID:
16453007
27.

Surfactant protein D is proatherogenic in mice.

Sorensen GL, Madsen J, Kejling K, Tornoe I, Nielsen O, Townsend P, Poulain F, Nielsen CH, Reid KB, Hawgood S, Falk E, Holmskov U.

Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2286-94. Epub 2005 Dec 30.

28.

The role of surfactant protein D in the colonisation of the respiratory tract and onset of bacteraemia during pneumococcal pneumonia.

Jounblat R, Clark H, Eggleton P, Hawgood S, Andrew PW, Kadioglu A.

Respir Res. 2005 Oct 28;6:126.

29.

Mast cells protect mice from Mycoplasma pneumonia.

Xu X, Zhang D, Lyubynska N, Wolters PJ, Killeen NP, Baluk P, McDonald DM, Hawgood S, Caughey GH.

Am J Respir Crit Care Med. 2006 Jan 15;173(2):219-25. Epub 2005 Oct 6.

30.

Design-based stereological analysis of the lung parenchymal architecture and alveolar type II cells in surfactant protein A and D double deficient mice.

Jung A, Allen L, Nyengaard JR, Gundersen HJ, Richter J, Hawgood S, Ochs M.

Anat Rec A Discov Mol Cell Evol Biol. 2005 Oct;286(2):885-90.

31.

Alveolar surfactant protein D content modulates bleomycin-induced lung injury.

Casey J, Kaplan J, Atochina-Vasserman EN, Gow AJ, Kadire H, Tomer Y, Fisher JH, Hawgood S, Savani RC, Beers MF.

Am J Respir Crit Care Med. 2005 Oct 1;172(7):869-77. Epub 2005 Jun 30.

32.

Innate immune collectin surfactant protein D enhances the clearance of DNA by macrophages and minimizes anti-DNA antibody generation.

Palaniyar N, Clark H, Nadesalingam J, Shih MJ, Hawgood S, Reid KB.

J Immunol. 2005 Jun 1;174(11):7352-8.

33.

Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa.

Ni M, Evans DJ, Hawgood S, Anders EM, Sack RA, Fleiszig SM.

Infect Immun. 2005 Apr;73(4):2147-56.

34.

Surfactant protein D deficiency influences allergic immune responses.

Schaub B, Westlake RM, He H, Arestides R, Haley KJ, Campo M, Velasco G, Bellou A, Hawgood S, Poulain FR, Perkins DL, Finn PW.

Clin Exp Allergy. 2004 Dec;34(12):1819-26.

PMID:
15663554
35.

Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species.

Atochina EN, Beck JM, Preston AM, Haczku A, Tomer Y, Scanlon ST, Fusaro T, Casey J, Hawgood S, Gow AJ, Beers MF.

Infect Immun. 2004 Oct;72(10):6002-11.

36.

Surfactant proteins in pulmonary alveolar proteinosis in adults.

Brasch F, Birzele J, Ochs M, Guttentag SH, Schoch OD, Boehler A, Beers MF, Müller KM, Hawgood S, Johnen G.

Eur Respir J. 2004 Sep;24(3):426-35.

37.

Infant pulmonary function in a randomized trial of fetal tracheal occlusion for severe congenital diaphragmatic hernia.

Keller RL, Hawgood S, Neuhaus JM, Farmer DL, Lee H, Albanese CT, Harrison MR, Kitterman JA.

Pediatr Res. 2004 Nov;56(5):818-25. Epub 2004 Aug 19.

PMID:
15319458
38.

GM-CSF mediates alveolar epithelial type II cell changes, but not emphysema-like pathology, in SP-D-deficient mice.

Ochs M, Knudsen L, Allen L, Stumbaugh A, Levitt S, Nyengaard JR, Hawgood S.

Am J Physiol Lung Cell Mol Physiol. 2004 Dec;287(6):L1333-41. Epub 2004 Aug 13.

39.

Pulmonary collectins modulate strain-specific influenza a virus infection and host responses.

Hawgood S, Brown C, Edmondson J, Stumbaugh A, Allen L, Goerke J, Clark H, Poulain F.

J Virol. 2004 Aug;78(16):8565-72.

40.

Surfactant protein B: structure and function.

Hawgood S.

Biol Neonate. 2004;85(4):285-9. Epub 2004 Jun 8. Review.

PMID:
15218284
41.

Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice.

Atochina EN, Gow AJ, Beck JM, Haczku A, Inch A, Kadire H, Tomer Y, Davis C, Preston AM, Poulain F, Hawgood S, Beers MF.

J Infect Dis. 2004 Apr 15;189(8):1528-39. Epub 2004 Mar 30.

PMID:
15073692
42.

Surfactant protein D binds genomic DNA and apoptotic cells, and enhances their clearance, in vivo.

Palaniyar N, Clark H, Nadesalingam J, Hawgood S, Reid KB.

Ann N Y Acad Sci. 2003 Dec;1010:471-5.

PMID:
15033772
43.
44.

Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia.

Keller RL, Hamrick SE, Kitterman JA, Fineman JR, Hawgood S.

Pediatr Crit Care Med. 2004 Mar;5(2):184-7.

PMID:
14987351
45.

A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia.

Harrison MR, Keller RL, Hawgood SB, Kitterman JA, Sandberg PL, Farmer DL, Lee H, Filly RA, Farrell JA, Albanese CT.

N Engl J Med. 2003 Nov 13;349(20):1916-24.

46.

Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung.

Brasch F, Ochs M, Kahne T, Guttentag S, Schauer-Vukasinovic V, Derrick M, Johnen G, Kapp N, Muller KM, Richter J, Giller T, Hawgood S, Buhling F.

J Biol Chem. 2003 Dec 5;278(49):49006-14. Epub 2003 Sep 16.

47.

Surfactant protein B in type II pneumocytes and intra-alveolar surfactant forms of human lungs.

Brasch F, Johnen G, Winn-Brasch A, Guttentag SH, Schmiedl A, Kapp N, Suzuki Y, Müller KM, Richter J, Hawgood S, Ochs M.

Am J Respir Cell Mol Biol. 2004 Apr;30(4):449-58. Epub 2003 Sep 11.

PMID:
12972403
48.

Surfactant protein-D, a mediator of innate lung immunity, alters the products of nitric oxide metabolism.

Atochina EN, Beers MF, Hawgood S, Poulain F, Davis C, Fusaro T, Gow AJ.

Am J Respir Cell Mol Biol. 2004 Mar;30(3):271-9. Epub 2003 Jul 18.

PMID:
12871850
49.

Neurodevelopmental outcome of infants supported with extracorporeal membrane oxygenation after cardiac surgery.

Hamrick SE, Gremmels DB, Keet CA, Leonard CH, Connell JK, Hawgood S, Piecuch RE.

Pediatrics. 2003 Jun;111(6 Pt 1):e671-5.

PMID:
12777584
50.

Surfactant protein A is a required mediator of keratinocyte growth factor after experimental marrow transplantation.

Haddad IY, Milla C, Yang S, Panoskaltsis-Mortari A, Hawgood S, Lacey DL, Blazar BR.

Am J Physiol Lung Cell Mol Physiol. 2003 Sep;285(3):L602-10. Epub 2003 May 9.

Supplemental Content

Loading ...
Support Center